A Dilemma for Governments: How to Pay for Million-Dollar Therapies

A wave of transformative but hugely expensive treatments is challenging the budgets of health systems in wealthy nations. Now countries with far fewer resources are wrestling with how to cover the therapies.
Source: NYT Health - Category: Consumer Health News Authors: Tags: Drugs (Pharmaceuticals) Health Insurance and Managed Care Genetic Engineering Babies and Infants Genetics and Heredity Children and Childhood Suits and Litigation (Civil) Spinal Muscular Atrophy Disabilities Novartis AG Brazil Zolgen Source Type: news